During a Testing Center run against the discharge-instruction summary template, several test cases fail because the generated summaries occasionally omit a medication dosage that was present in the source record. What is the appropriate next step in the lifecycle?

The appropriate lifecycle step is to investigate the failing cases, refine the template’s instructions and/or grounding so dosage information is consistently included, and re-run the tests before considering rollout. Testing Center findings help reveal defects to address before deployment; treating an omitted medication dosage as harmless wording variation and proceeding without changes or retesting leaves a real failure unresolved. The omission is specific and clinically relevant, so immediately rolling the template out on the assumption that some failure rate is acceptable would expose users to a known defect rather than confirm that the summary works as intended. Deleting failing test cases to make the go-live report look acceptable would misrepresent the results and defeat testing’s purpose; the evidence should prompt a fix, not be hidden. One exam caveat: passing tests support a rollout decision but do not justify ignoring a known failure simply because findings are described as advisory. As a practical check, verify that the revised template includes the source medication dosage in the previously failing cases when you re-run them, then consider rollout only after confirming the fix.